FDA panel recommends Chelsea Therapeutics'
February 23, 2012 at 16:24 PM EST
WASHINGTON, Feb 23 (Reuters) - Chelsea Therapeutics International Ltd's hypotension drug Northera should be approved for use in the United States, a committee of independent experts recommended on Thursday.
